WVE

Wave Life Sciences
WVE

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$1.07B
EV
$859.63M
Shares Outstanding
166.38M
Beta
-1.05

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$20.38
P/E 2025E
-
P/Revenue 2025E
18.25x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Wave Life Sciences Ltd.

gainify
WVE

Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company’s RNA medicines platform, PRISM, combines multiple modalities,...

Sector

Healthcare

Industry

Biotechnology

CEO

Bolno, Paul B.

Employees

288

IPO Date

2015-11-11

Headquarters

Marina One East Tower, 7 Straits View No.12-00, Singapore 018936, Singapore

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.